On April 12, 2016, the inauguration ceremony of Xianjian Technology's cardiac pacemaker production line was held in Shenzhen Science and Technology Park.
As the world's second largest congenital heart disease occluder supplier and the most promising Chinese brand in the cardiovascular field, Xianjian Technology is the world leader in cardiac pacemakers and the global medical device manufacturing giant in 2014. After reaching a strategic cooperation agreement in the year, after two years of cooperation, the pacemaker production line in line with global standards was officially completed on April 12.
The leaders of the conference included Mr. He, Director of the Shenzhen Investment Promotion Agency, Mr. Xie Yuehui, Chairman of Xianjian Technology, leaders of Medtronic, and two experts in the field of cardiac medicine. The inauguration ceremony attracted the attention of many investors and news media.
During the meeting, Mr. Xie Yuehui, Chairman of Xianjian Technology Co., Ltd. and the leader of Medtronic, respectively, said that this strategic cooperation is mutually beneficial and win-win. Xianjian Technology takes advantage of Medtronic's leading technology and brand effect in the production of pacemakers, taking a new step in the production of domestic pacemakers. At the same time, Xianjian Technology also provides a large number of clinical trial materials for Medtronic. It laid a solid foundation for Medtronic to further expand the Chinese market.
In the face of the current situation that domestic pacemakers mainly rely on imports, the completion of this production line of Xianjian Technology is undoubtedly of epoch-making significance. According to research by Prof. Huawei, experts from the conference, about 540,000 people die of heart disease deaths each year in China, 80% of which can be cured by installing a pacemaker. Actually, the number of people installed in China is less than 70,000 per year. On-site expert Professor Huang Congxin said that because of the multi-faceted factors such as price, the installation of Chinese pacemakers is very different from that of developed countries.
The pacemaker produced by Xianjian Technology is no different from the international giant Medtronic in quality, but it has obvious price advantage, which will bring good news to many patients in China. Mr. Xie Yuehui said that the company's annual production capacity is about 100,000 units. It is very easy to increase the production quantity according to market demand in the later stage, which will greatly fill the market gap of domestic pacemakers.
At the meeting, Professor Huang Congxin called for the price of domestic medical bidding to be rationalized and allocated, and could not blindly pursue low prices and lack quality monitoring.
Cannulated Screw,Canulated Double Screw,Titanium Bone Screw,Titanium Cannulated Screw
Medton Medical , https://www.medtonmedical.com